A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.
about
Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapyMolecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.The Management of Classical Hodgkin's Lymphoma: Past, Present, and FutureClinical Trials and Molecular Radiotherapy.Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.Immunotherapy in pediatric malignancies: current status and future perspectivesTargeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.
P2860
Q28731819-8F8D9400-A2B3-48C8-BEE1-E2DDBA7E3E71Q31085503-F40774A1-2B87-49CE-8652-E36ADA9B119AQ35038852-7D07017D-60B7-4A9D-A056-FAE81D79F1A9Q35682087-BDDE8EDC-80BF-4A0D-893E-F434F2BB12C6Q36261159-C59291DF-3C7D-42AC-95C7-F07E0D839F77Q36691818-5D1734F3-B499-4F52-A476-D1A4E0C58CA9Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2Q39338052-0E56EB86-5B49-4AD9-BF59-5CB68C17879DQ45227780-36C1086D-4230-47B3-BB30-B3E6F371980A
P2860
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@ast
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@en
type
label
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@ast
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@en
prefLabel
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@ast
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@en
P2093
P1476
A Phase I Clinical Trial of CH ...... ents with Refractory Lymphoma.
@en
P2093
Alan J Green
Alan Ramsay
Alessandra Malaroda
Anmol Malhotra
Christopher McNamara
Gairin Dancey
John Buscombe
John Violet
Natalie Griffin
Nicholas Woodward
P304
P356
10.1158/1078-0432.CCR-09-1421
P407
P577
2009-12-01T00:00:00Z